EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹6,658 Cr | ₹5,986 Cr | ₹5,855 Cr | ₹6,056 Cr | ₹5,049 Cr |
What is the latest Revenue of EMCURE PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹6,658 Cr |
Mar2023 | ₹5,986 Cr |
Mar2022 | ₹5,855 Cr |
Mar2021 | ₹6,056 Cr |
Mar2020 | ₹5,049 Cr |
How is Revenue of EMCURE PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹6,658 Cr | 11.23 | |
Mar2023 | ₹5,986 Cr | 2.23 | |
Mar2022 | ₹5,855 Cr | -3.32 | |
Mar2021 | ₹6,056 Cr | 19.96 | |
Mar2020 | ₹5,049 Cr | - |
Compare Revenue of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹25,725.6 Cr | 0.9% | 3.2% | 0.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 0.9% |
3.2% |
0.1% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses